What diseases have high calprotectin?

High calprotectin is a clue that inflammation is active in the gut. This article explains what calprotectin is, why fecal calprotectin levels matter, and which diseases are most often associated with elevated results. You’ll learn how clinicians use this immune marker within gastrointestinal diagnostics, when high values suggest conditions such as inflammatory bowel disease, and why symptoms alone don’t reveal the full picture. We’ll also explore how the gut microbiome influences intestinal inflammation and how microbiome testing can provide deeper, personalized insight. By the end, you’ll understand what high calprotectin can and cannot tell you—so you can discuss appropriate next steps with a qualified clinician.

Understanding Calprotectin: A Key Indicator of Gut Health

Calprotectin is a protein complex (S100A8/S100A9) released primarily by neutrophils, a type of white blood cell that responds quickly to injury and infection. As an immune response indicator, calprotectin helps limit microbial growth by binding metals like zinc and manganese and has antimicrobial effects. Because it is abundant, resistant to breakdown, and excreted in stool when neutrophils migrate into the intestinal lumen, calprotectin is particularly useful in gastrointestinal diagnostics.

The primary clinical focus is fecal calprotectin. Measuring calprotectin in stool provides a noninvasive window into inflammatory activity along the gastrointestinal tract, especially the colon but also the small intestine. Elevated fecal calprotectin levels suggest neutrophil-rich inflammation in the gut wall. This helps clinicians differentiate inflammatory disorders (such as inflammatory bowel disease) from non-inflammatory conditions (such as irritable bowel syndrome) and decide whether further evaluation—like endoscopy—may be warranted.

Core Explanation of Calprotectin and Its Relevance to Disease

When the intestinal lining is inflamed, neutrophils move from blood vessels into the mucosa and eventually into the gut lumen. As they degranulate or break down, they release calprotectin, which remains stable in feces. Because this protein closely tracks neutrophil activity, higher fecal calprotectin levels generally reflect more intense mucosal inflammation.

While exact ranges vary by laboratory, many adult reference ranges categorize fecal calprotectin roughly as: - Normal: less than about 50 µg/g - Borderline or mildly elevated: approximately 50–200 µg/g (some labs use up to 250) - Clearly elevated: greater than about 200–250 µg/g These thresholds are guides, not absolutes. Age matters (infants and young children have naturally higher levels), and so do infections, medications, and sample variability. Nonetheless, elevated fecal calprotectin strongly suggests an inflammatory process, making it one of the most studied inflammatory bowel disease markers.

Importantly, not all increases indicate chronic disease. The immune system is adaptive, and temporary spikes can occur during acute infections or after certain exposures. Distinguishing a short-lived, appropriate response from ongoing, pathological inflammation is the clinical challenge—and why fecal calprotectin is interpreted alongside history, symptoms, other labs, and imaging.

Why This Topic Matters for Gut Health

Intestinal inflammation affects digestion, nutrient absorption, gut barrier integrity, and overall well-being. Unaddressed inflammation can worsen quality of life and, in specific diseases, contribute to complications like strictures, bleeding, or malabsorption. Because many gastrointestinal symptoms overlap across conditions, people can be misdiagnosed or experience diagnostic delays. Understanding what high calprotectin means can support earlier, more accurate identification of conditions that need medical attention, help differentiate functional disorders from inflammatory diseases, and guide decisions about whether endoscopy or other tests are necessary.

At the same time, calprotectin isn’t a diagnosis. It’s a signal. Recognizing its value—and its limitations—can prevent unnecessary worry or false reassurance and promote informed, individualized care.

What Diseases Have High Calprotectin?

Elevated fecal calprotectin is most often associated with conditions that drive neutrophil-predominant inflammation in the gut. Below are the key categories, with brief notes on what is known about their relationship to calprotectin.

Inflammatory Bowel Disease (IBD): Crohn’s Disease and Ulcerative Colitis

IBD is the classic cause of high fecal calprotectin. In ulcerative colitis and Crohn’s disease, immune activity targets the gut lining, bringing neutrophils into the mucosa and lumen. Calprotectin levels often correlate with endoscopic and histologic activity; higher values tend to reflect more severe inflammation. Clinically, fecal calprotectin is used to help distinguish IBD from irritable bowel syndrome (IBS), to monitor disease activity between endoscopies, and to evaluate response to therapy or detect relapse risk. While not perfect, calprotectin has high sensitivity for active IBD and is one of the most useful noninvasive inflammatory bowel disease markers available.

Pouchitis (Inflammation of an Ileal Pouch)

People who have had their colon removed and an ileal pouch created (for example, after surgery for ulcerative colitis) may develop pouchitis. Fecal calprotectin is commonly elevated in pouchitis and can help track inflammatory activity in the pouch, often aligning with symptom severity and endoscopic findings.

Infectious Colitis and Gastroenteritis

Bacterial infections such as Campylobacter, Salmonella, Shigella, enterohemorrhagic or enteroinvasive E. coli, and Clostridioides difficile frequently raise fecal calprotectin, sometimes to very high levels. Parasitic infections (e.g., Entamoeba histolytica, Giardia) and severe viral gastroenteritis can also increase levels. In these settings, calprotectin reflects an appropriate immune response to pathogens. Elevated results typically fall as the infection resolves. Because symptoms can resemble IBD flares, stool tests (including pathogen detection) are often necessary to clarify the cause.

Microscopic Colitis

Microscopic colitis (lymphocytic or collagenous colitis) presents with chronic watery diarrhea and usually requires biopsy for diagnosis. Fecal calprotectin may be normal to mildly elevated in many cases, though some individuals show higher values during active inflammation. Thus, a normal calprotectin does not rule out microscopic colitis, but an elevated level may increase the suspicion of an inflammatory cause of diarrhea.

Diverticulitis and Symptomatic Diverticular Disease

Acute diverticulitis—localized inflammation of colonic diverticula—often elevates fecal calprotectin, and levels may correlate with the inflammatory burden. In uncomplicated diverticulosis (outpouchings without active inflammation), calprotectin is typically not significantly elevated. In symptomatic uncomplicated diverticular disease, values may be mildly to moderately increased during inflammatory episodes.

Colorectal Neoplasia (Cancer and Advanced Adenomas)

Fecal calprotectin can be higher in people with colorectal cancer or advanced adenomas due to mucosal inflammation and ulceration associated with neoplastic processes. However, calprotectin is not a screening test for colorectal cancer. Many benign inflammatory conditions can also elevate levels, and some cancers may not produce a rise. Abnormal calprotectin in older adults or those with alarm features (e.g., rectal bleeding, unexplained weight loss, iron-deficiency anemia) may prompt further evaluation with colonoscopy based on clinical judgment.

Ischemic Colitis

When blood flow to a segment of the colon is reduced, the lining becomes injured and inflamed, often causing abdominal pain and blood in the stool. Fecal calprotectin usually rises in ischemic colitis because neutrophils flood the injured mucosa. The magnitude of elevation varies with severity and extent of ischemia.

Drug-Induced Intestinal Injury (NSAIDs and Others)

Nonsteroidal anti-inflammatory drugs (NSAIDs) can injure the small intestine and colon, leading to NSAID enteropathy and colitis. Fecal calprotectin may be elevated in individuals taking these medications, particularly with chronic use or higher doses. Some studies suggest proton pump inhibitors (PPIs) may be associated with mild increases in fecal calprotectin in certain populations, though findings are mixed. As with all results, medication history is essential when interpreting values.

Untreated Celiac Disease

While celiac disease is primarily an immune reaction to gluten that targets the small intestinal mucosa, some people with active, untreated celiac disease show mildly elevated fecal calprotectin. Marked elevations are less typical than in IBD or severe infections. Normalization often parallels mucosal healing after gluten exclusion.

Radiation Proctitis/Colitis

Pelvic radiation therapy can inflame the rectum and colon (radiation proctitis or colitis). Fecal calprotectin often tracks with the degree of mucosal injury and inflammation during and after radiation exposure.

Necrotizing Enterocolitis (NEC) in Infants and Other Pediatric Considerations

In neonates, especially preterm infants, fecal calprotectin is naturally higher and highly variable. In conditions like necrotizing enterocolitis, levels can be substantially elevated, reflecting significant mucosal inflammation and injury. Pediatric reference ranges differ by age, and interpretation in infants requires specialized clinical context.

Graft-Versus-Host Disease (GI GVHD)

After hematopoietic stem cell transplantation, immune responses against host tissues can inflame the intestinal tract. Elevated fecal calprotectin may occur in gastrointestinal GVHD and has been studied as a noninvasive marker of mucosal inflammation alongside other clinical indicators.

Eosinophilic and Food-Related Colitides

Eosinophilic gastrointestinal disorders and certain non–IgE-mediated food-related colitides can produce mucosal inflammation and increased fecal calprotectin. Levels vary and may not always reach the ranges seen in severe neutrophil-predominant conditions, but they can be elevated during active disease.

Cystic Fibrosis and Other Conditions with Secondary Intestinal Inflammation

People with cystic fibrosis may exhibit intestinal inflammation due to altered mucus properties, microbiome changes, and digestive factors, sometimes with elevated fecal calprotectin. Other systemic conditions that secondarily inflame the gut can occasionally elevate results, though magnitudes and patterns vary widely.

Small Intestinal Bacterial Overgrowth (SIBO): A Nuanced Note

SIBO can cause bloating, diarrhea, and malabsorption, but the relationship with fecal calprotectin is inconsistent. Some individuals with SIBO show normal levels, while others present mild elevations, possibly when mucosal irritation or coexisting conditions are present. Elevated calprotectin in suspected SIBO should prompt evaluation for alternative or concurrent inflammatory causes.

What About IBS?

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder and typically does not elevate fecal calprotectin. This makes calprotectin useful in distinguishing IBS from inflammatory causes of similar symptoms. Still, borderline elevations can occur transiently due to infections, medications, or other factors, so context remains essential.

Recognizing Symptoms and Signals Associated with High Calprotectin

Symptoms that often accompany conditions linked to high fecal calprotectin include: - Abdominal pain or cramping - Diarrhea, sometimes with blood or mucus - Urgency and frequent bowel movements - Unexplained weight loss - Fatigue, low energy, and general malaise - Fever during acute infections or severe inflammatory flares Notably, these symptoms are not specific to any one condition. Mild symptoms can arise from benign, self-limited causes, while severe disease can sometimes present subtly. That ambiguity is exactly why objective biomarkers, such as calprotectin, can be helpful in triage and decision-making.

The Challenge of Individual Variability and Diagnostic Uncertainty

Fecal calprotectin levels vary across individuals and life stages. Infants and toddlers naturally run higher values. Older adults may show slightly increased baseline levels compared to younger adults. Recent infections, transient gastroenteritis, or even intense endurance exercise may nudge values upward for a short time. Medications—including NSAIDs and possibly PPIs—can contribute, as can underlying conditions not primarily rooted in the gut.

Laboratory cutoffs differ, and single measurements can sometimes mislead due to day-to-day fluctuations. For borderline or unexpected results, clinicians may recommend repeating the test, pausing certain medications (when safe), or timing collection away from acute illnesses. Recognizing these nuances helps avoid both overreaction to false alarms and missed opportunities to catch significant disease early.

Why Symptoms Alone Do Not Reveal the Root Cause

Diarrhea, abdominal pain, bloating, and fatigue are common across many disorders: IBD, infectious colitis, celiac disease, microscopic colitis, ischemic colitis, medication-induced injury, and IBS can all present similarly. Relying on symptoms alone risks misdiagnosis. Conversely, focusing on one lab result in isolation can be equally misleading. The most reliable path integrates history, exam findings, fecal calprotectin and other biomarkers, stool studies for infection when appropriate, and imaging or endoscopy when indicated.

In practice, a low fecal calprotectin in someone with chronic diarrhea and no alarm features often supports a functional diagnosis (like IBS), potentially sparing invasive procedures. A high or persistently elevated value, especially with red flags, strengthens the case for further gastrointestinal evaluation. In both scenarios, the aim is to move beyond guesswork to targeted, evidence-based care.

The Role of the Gut Microbiome in Intestinal Inflammation

The intestinal microbiome—a dense community of bacteria, archaea, fungi, and viruses—interacts constantly with the immune system. A balanced microbiome supports barrier integrity, produces beneficial metabolites (such as short-chain fatty acids like butyrate), and educates immune responses to avoid overreaction. Dysbiosis—loss of beneficial organisms, reduced diversity, or overgrowth of pathobionts—can disrupt this balance.

When the barrier is compromised or the microbial composition shifts toward pro-inflammatory species, immune cells respond. Pattern-recognition receptors in the mucosa detect microbial fragments like lipopolysaccharide (LPS) and flagellin, triggering signaling cascades that recruit neutrophils. Neutrophil influx increases calprotectin in the gut lumen. Over time, this feedback loop may perpetuate inflammation, further alter microbial ecology, and heighten sensitivity to diet or stressors. While dysbiosis is not the sole cause of inflammatory diseases, it is an important modulator of intestinal inflammation for many people.

How Microbiome Imbalances May Contribute to High Calprotectin Levels

Specific microbial features have been associated with higher intestinal inflammation: - Reduced abundance of anti-inflammatory commensals, such as Faecalibacterium prausnitzii and other butyrate-producing Firmicutes - Overrepresentation of Proteobacteria (e.g., Escherichia/Shigella), which can drive LPS-mediated immune activation - Increases in mucin-degrading or mucus-adherent species that thin the protective mucus layer - Expansion of opportunistic fungi (e.g., Candida) in certain contexts - Decreased microbial diversity, which may reduce ecosystem resilience against inflammatory perturbations These patterns can lead to impaired barrier function (“leaky gut”), altered bile acid metabolism, and shifts in T-cell balance (such as Th17 responses), all of which can elevate local neutrophil activity and calprotectin. Importantly, these features are not diagnostic on their own; rather, they offer mechanistic context for why some people experience more persistent or severe inflammation than others.

Microbiome Testing as a Diagnostic and Personalization Tool

Microbiome testing analyzes the composition of microbes in the stool, often via DNA sequencing methods. While it is not a clinical diagnostic test for IBD or other specific diseases, it can complement medical evaluation by highlighting: - Microbial diversity and overall ecosystem balance - Relative abundance of beneficial commensals and potential pathobionts - Presence of select pathogens or toxin genes (depending on the platform) - Signals that suggest heightened immune activation or reduced butyrate potential (inferred from community structure) In the context of elevated fecal calprotectin, a stool microbiome profile can provide additional insight into factors that might be sustaining inflammation, help identify hidden imbalances, and guide individualized discussions about diet, lifestyle, and follow-up with clinicians. For readers seeking a structured way to explore their gut ecosystem, see this option for a microbiome test.

Who Should Consider Microbiome and Gut Diagnostics

Microbiome testing and related gut assessments may be informative for: - Individuals with persistent gastrointestinal symptoms (diarrhea, urgency, bloating, abdominal pain) despite basic workup - People with elevated fecal calprotectin levels whose diagnosis remains unclear after initial evaluation - Those at higher risk for intestinal inflammation (e.g., family history of IBD) who want to understand non-diagnostic, educational markers of microbial balance - Individuals interested in a personalized approach to gut health that considers microbial ecology alongside medical care Testing is most useful when results will be reviewed in context—ideally in collaboration with a healthcare professional—rather than interpreted as stand-alone answers.

Decision-Support: When Microbiome Testing Is Recommended

Situations where microbiome testing may provide actionable insight include: - Unclear diagnosis after standard gastrointestinal diagnostics, where microbial context might suggest next steps - Recurring or chronic symptoms that persist despite initial treatment, supporting a re-examination of possible microbial drivers - Elevated inflammatory markers, such as calprotectin, when you want to learn whether dysbiosis patterns could be contributing - Before starting broad interventions (e.g., elimination diets, probiotics), to establish a baseline for later comparison If you are considering this type of insight, a noninvasive stool microbiome analysis can help frame a more personalized discussion with your clinician and nutrition professional.

Connecting the Dots: From Symptoms to Insightful Diagnostics

Putting the pieces together starts with your story: symptom pattern, duration, triggers, and red flags. Fecal calprotectin then provides a quantifiable snapshot of neutrophil-driven inflammation. If values are elevated, stool testing for pathogens, celiac serologies (if indicated), imaging, or endoscopy might follow, depending on the clinical picture. Where appropriate, stool microbiome profiling can overlay a systems-level view of microbial balance, potential pathobionts, and ecosystem resilience. None of these replace clinical evaluation; together, they reduce guesswork and allow a targeted plan.

Because each person’s biology and microbiome are unique, the same symptoms can stem from different root causes. Integrating fecal calprotectin with a deeper look at the gut ecosystem—when warranted—can turn a generic label (“chronic diarrhea”) into a more nuanced understanding that guides next steps. If you decide to explore your gut ecology, you can explore a microbiome testing option designed to educate and inform discussions with your care team.

Key Takeaways

• Fecal calprotectin is a stable marker of neutrophil-driven intestinal inflammation and a valuable tool in gastrointestinal diagnostics.
• High calprotectin commonly occurs in IBD (Crohn’s disease, ulcerative colitis), infectious colitis, diverticulitis, ischemic colitis, and other inflammatory conditions.
• IBS usually shows normal calprotectin, helping differentiate functional symptoms from inflammatory disease.
• Medications (like NSAIDs) and transient infections can raise calprotectin; interpretation always requires clinical context.
• Symptoms alone rarely reveal the root cause; objective testing reduces diagnostic uncertainty and misclassification.
• The gut microbiome modulates immune responses; dysbiosis can contribute to barrier dysfunction and elevated inflammation.
• Microbiome testing is not diagnostic but can reveal patterns—diversity, potential pathobionts, and ecosystem balance—that inform personalized strategies.
• Repeat calprotectin testing may be useful for borderline or unexpected results, or to monitor inflammatory activity over time.
• Collaborating with a clinician ensures that calprotectin results, microbiome insights, and symptoms are integrated into safe, appropriate next steps.

Q&A: Common Questions About High Calprotectin

What is calprotectin and why is it measured in stool?

Calprotectin is a protein released by neutrophils during inflammation. Measuring it in stool provides a noninvasive way to estimate intestinal mucosal inflammation, helping clinicians distinguish inflammatory from non-inflammatory gastrointestinal conditions and decide whether more testing is needed.

What fecal calprotectin level is considered high?

Cutoffs vary by lab, but many use less than 50 µg/g as normal in adults, 50–200 µg/g as borderline or mildly elevated, and more than 200–250 µg/g as clearly elevated. Interpretation depends on age, symptoms, medications, and other findings, so results should be reviewed in context with a clinician.

Which diseases most often raise fecal calprotectin?

Inflammatory bowel disease (Crohn’s disease and ulcerative colitis), infectious colitis (e.g., Campylobacter, Salmonella, C. difficile), diverticulitis, ischemic colitis, and radiation colitis frequently elevate calprotectin. It can also be increased in microscopic colitis, untreated celiac disease (often mildly), drug-induced injury (e.g., NSAIDs), and some other inflammatory states.

Can IBS raise calprotectin?

IBS is usually not associated with elevated fecal calprotectin. A low calprotectin supports a functional diagnosis in the right clinical context. Borderline elevations can occur due to other factors (like mild infections or medications), so persistent symptoms may still warrant further evaluation.

Do medications like NSAIDs or PPIs affect fecal calprotectin?

Yes. NSAIDs can injure the intestinal lining and raise fecal calprotectin. Some studies suggest PPIs may be associated with mild increases in certain populations, but evidence is mixed. Always inform your clinician about medications when interpreting test results.

How do clinicians distinguish infectious colitis from IBD when calprotectin is high?

They consider timing, exposures (e.g., recent travel, contaminated food), systemic symptoms like fever, and order stool pathogen testing. In some cases, imaging or endoscopy may be needed. Calprotectin indicates inflammation but does not specify the cause on its own.

Can diet or stress raise calprotectin?

Diet and stress can influence gut symptoms and the microbiome, but they are not consistent, direct drivers of marked calprotectin elevations. Significant increases generally reflect mucosal inflammation. However, individual variability means lifestyle factors may modulate the inflammatory milieu in some people.

Is fecal calprotectin reliable in children and older adults?

It is useful but must be interpreted with age-appropriate reference ranges. Infants and young children naturally have higher baseline levels, and older adults may have modestly higher values. Pediatric and geriatric assessments should always account for age-specific norms and clinical context.

How often should fecal calprotectin be retested?

It depends on why it was ordered. For borderline or unexpected results, clinicians may repeat testing after a short interval, especially if medications could be influencing values. In known IBD, calprotectin can be monitored periodically to assess disease activity or response to therapy, as guided by the care team.

Can strenuous exercise affect fecal calprotectin?

Intense endurance exercise can transiently increase intestinal permeability and may mildly affect inflammatory markers in some individuals. However, large and persistent calprotectin elevations typically reflect underlying gastrointestinal inflammation rather than exercise alone.

Can microbiome testing replace calprotectin or colonoscopy?

No. Microbiome testing is an educational tool that provides ecosystem context—diversity, potential pathobionts, and balance—but it is not diagnostic for IBD or other diseases. It complements, rather than replaces, clinical evaluation, calprotectin, stool pathogen tests, imaging, or endoscopy when indicated.

What should I do if my fecal calprotectin is high?

Discuss the result with your clinician. They may suggest repeating the test, reviewing medications, checking stool for pathogens, or proceeding to imaging or endoscopy if warranted. If you want to understand potential microbial contributors, a contextual tool like a microbiome testing kit can add personalized insight to guide conversations about next steps.

Conclusion: Embracing a Personalized Approach to Gut Health

High fecal calprotectin signals neutrophil-driven intestinal inflammation and is most commonly associated with conditions like IBD and infectious colitis—yet it does not diagnose a specific disease by itself. Because symptoms overlap across many gastrointestinal disorders, objective markers like calprotectin help reduce uncertainty and direct appropriate next steps. The gut microbiome is a key modulator of inflammation; when dysbiosis and barrier dysfunction are present, they can amplify immune activation and sustain elevated calprotectin.

For many people, the most effective path forward is integrative and personalized: combine symptom history, calprotectin and other labs, targeted imaging or endoscopy when needed, and—where helpful—stool microbiome profiling to illuminate ecosystem patterns. This approach moves from guessing to guided action, supporting safer, more precise decisions for long-term gut health.

Keywords

calprotectin, fecal calprotectin levels, intestinal inflammation, inflammatory bowel disease markers, Crohn’s disease, ulcerative colitis, infectious colitis, diverticulitis, ischemic colitis, microscopic colitis, celiac disease, pouchitis, NSAID enteropathy, gastrointestinal diagnostics, immune response indicators, gut microbiome, dysbiosis, microbial diversity, pathobionts, gut barrier integrity